8/7/2019 Extra Pyramidal Side Effects
1/27
8/7/2019 Extra Pyramidal Side Effects
2/27
Neurologic syndromes in which abnormalmovement occur due to a disturbance offluency and speed of voluntary movement or
the presence of unintended extra movements
8/7/2019 Extra Pyramidal Side Effects
3/27
Results from dysfunction of the extrapyramidalsystem
Basal ganglioncaudate, putamen, globus
pallidus, subthalamic nucleus, and substantianigra
motor area of cortex--> basalgangalion(organizing movement commands) -->
motor area of cortex# affects the size and speed of movements
# selection of components of movements or the sequencingof multi-step movements
8/7/2019 Extra Pyramidal Side Effects
4/27
Direct pathway
Dopamine D1 type medium spiny neuron internal portion of globuspallidus ventral anterior/ventral lateral region of thalamus c
ortexIndirect pathway
Dopamine D2 type medium spiny neuron external portion of globuspallidus subthalamic nucleus internal portion of globus pallidus
ventral anterior/ventral lateral region of thalamus cortex
8/7/2019 Extra Pyramidal Side Effects
5/27
8/7/2019 Extra Pyramidal Side Effects
6/27
EPS secondary to pharmacologic agents are themost common.
The risk of developing a drug-induced EPS begins
at the onset of treatment with an offending agent. Acutely: within hours or a few days
Subacutely: over several weeks
Late or delayed onset: six months or longer afterexposure(tardive)
short-term therapy of minimal therapeutic dosagesshould be the strategy employed
8/7/2019 Extra Pyramidal Side Effects
7/27
Five classes of drugs are known to affect centraldopaminergic systems
Central stimulantsact as indirect dopamine agonist ex.
Amphetamine Levodopaa precursor of dopamine
Direct dopamine agonistex. Bromocriptine
Presynaptic dopamine antagonists ex. Reserpine
Antagonize or block central dopamine receptors
neuroleptics, metoclopramideprimperam
8/7/2019 Extra Pyramidal Side Effects
8/27
Acute dystonia
Parkinsonism
Akathisia
Tardive dyskinesia
8/7/2019 Extra Pyramidal Side Effects
9/27
8/7/2019 Extra Pyramidal Side Effects
10/27
Dystonia (from Greek, meaning altered muscletone) refers to a syndrome of involuntarysustained or spasmodic muscle contractions
involving co-contraction of the agonist and theantagonist. The movements are usually slowand sustained, and they often occur in arepetitive and patterned manner; however,
they can be unpredictable and fluctuate. Thefrequent abnormal posturing and twisting canbe painful and functionally disabling.
8/7/2019 Extra Pyramidal Side Effects
11/27
focal dystonia
30 per 100,000
generalized dystonia
3 per 100,000
5 10 times greater in Ashkenazi Jewish
8/7/2019 Extra Pyramidal Side Effects
12/27
1. Primary dystonia
no structural abnormality in the CNS(oftengenetic)
Childhood onset idiopathic torsion dystonia(DYT-1)
Adult onset idiopathic dystonia (focal,
segmental)
8/7/2019 Extra Pyramidal Side Effects
13/27
Secondary (Acquired)
structural lesion (basal ganglia putamen, globus
pallidus, subthalamic nucleus or thalamus)
S
troke, tumor, AVM, injury perinatal hypoxia (associated with cerebral palsy)
CNS infections, inflammatory disorders
toxins cyanide (P), carbon monoxide, methylalcohol(GP)
drug induced (tardive dystonia) neuroleptics,
antiemetics, antiepileptics
acute dystonia reaction - neuroleptics
8/7/2019 Extra Pyramidal Side Effects
14/27
Drug-induced supersensitivity of striataldopamine receptors or abnormality of gammaaminobutyric acid (GABA) ergic neurons are
proposed mechanisms for some drug-induceddystonias.
8/7/2019 Extra Pyramidal Side Effects
15/27
Symptoms vary according to the kind ofdystonia involved. In most cases, dystoniatends to lead to abnormal posturing,
particularly on movement. Many sufferershave continuous pain, cramping and relentlessmuscle spasms due to involuntary musclemovements. Other motor symptoms are
possible including lip smacking.[
8/7/2019 Extra Pyramidal Side Effects
16/27
Parkinson's disease
essential tremor
carpal tunnel syndrome
TMD
Tourette's syndrome or other neuromuscularmovement disorders.
8/7/2019 Extra Pyramidal Side Effects
17/27
Electrical sensors (EMG) inserted into affectedmuscle groups, while painful, can provide adefinitive diagnosis by showing pulsating
nerve signals being transmitted to the muscleseven when they are at rest.
8/7/2019 Extra Pyramidal Side Effects
18/27
The functional impact of dystonia varies from barelynoticeable to severely disabling. Dystonias can have aprofound effect on a patient's personal, vocational, andemotional life and can impact his/her ability to liveindependently. Psychologic counseling and participation in
support groups are vital adjuncts to medical and physicalapproaches in the multidisciplinary management ofdystonia.
The options to medically manage dystonic movements havetraditionally been 4-fold; they consist of the following:
Rehabilitative therapies Oral medications Neurochemolytic interventions Surgery
8/7/2019 Extra Pyramidal Side Effects
19/27
As with most movement disorders, dystonia maybe influenced by fatigue, anxiety, relaxation, orsleep. Thus, attention to overall health,environment, and stressors can make dystoniamore manageable.[10, 11]
Dystonic movements are often exacerbated ortriggered by voluntary or intentional movementsof the same or other body parts. Involuntary
movements can be transiently suppressed by acontact stimulus, such as placing a hand on theipsilateral or contralateral side of the face or neckof a patient with spasmodic torticollis.
8/7/2019 Extra Pyramidal Side Effects
20/27
Physical therapy techniques (eg, massage),slow stretching, and physical modalities (eg,ultrasonography, biofeedback) are sometimes
helpful in persons with focal or regionaldystonias. Patients with generalized dystoniaoften benefit from gait and mobility training, aswell as from instruction in the use of assistive
devices.
8/7/2019 Extra Pyramidal Side Effects
21/27
8/7/2019 Extra Pyramidal Side Effects
22/27
Successful drug therapy often requirescombinations of several medications, withchoices generally guided by empirical trials
and adverse effect profiles.Doses should beslowly increased over the course of weeks ormonths until the therapeutic benefit isoptimized or until adverse effects occur. In
most patients, discontinuation of the drugsrequires tapering to prevent withdrawalsymptoms.
8/7/2019 Extra Pyramidal Side Effects
23/27
Baclofen, given intrathecally by an implantedpump, can be very effective in certain types ofdystonia, especially if spasticity co-exists.[9]Due
to the low prevalence of side effects when themedicine is delivered into the cerebrospinalfluid, the ability to deliver the medicinecontinuously, and the ability to test the
therapeutic effect prior to proceeding withsurgery, this option may provide effectivetreatment for many patients.
8/7/2019 Extra Pyramidal Side Effects
24/27
Neurochemolysis of dystonic muscles isanother important therapeutic option.Botulinum toxins or phenol/alcohol injections
have become powerful tools in improving thesymptomatic treatment of focaldystonias.These injections temporarily reducethe ability of the muscles to contract and may
be the treatment of choice for blepharospasm,cervical dystonia, and hemifacial spasm.
8/7/2019 Extra Pyramidal Side Effects
25/27
Botulinum toxins are produced by the gram-negative bacterium Clostridium botulinum andact by inhibiting the presynaptic release of
acetylcholine at the neuromuscular junction. Ofthe 7 immunologically distinct botulinum toxinserotypes, only types A and B are approved forclinical use. Onset of effect takes several days
after injection.
8/7/2019 Extra Pyramidal Side Effects
26/27
Surgical options for intractable dystoniasinclude altering the location or length ofproblematic muscles, but this is rarely
successful. Other techniques includetransection of the spinal accessory nerve forcervical dystonia, stereotactic thalamotomy orpallidotomy for generalized dystonia, and deep
brain stimulation (DBS)
8/7/2019 Extra Pyramidal Side Effects
27/27
Thorough neurologic, physiatric,neuropsychologic, and physical therapyevaluations are important prior to
consideration for surgery. Because of the risk of significant comorbidity,
these approaches are reserved for patients withdisabling dystonia in whom other treatment
modalities have been exhausted.